Acelrx Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acelrx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Acelrx Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acelrx Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $4.8k | 4.5k | 1.05 |
| 2025-03-31 | $20 | 40 | 0.50 |
| 2024-12-31 | $19 | 39 | 0.51 |
| 2024-09-30 | $121 | 141 | 0.86 |
| 2024-06-30 | $37 | 42 | 0.88 |
| 2024-03-31 | $67 | 66 | 1.03 |
| 2023-12-31 | $39 | 54 | 0.74 |
| 2023-09-30 | $22 | 39 | 0.59 |
| 2023-06-30 | $28 | 25 | 1.12 |
| 2023-03-31 | $0 | 175 | 0.00 |
| 2022-12-31 | $0 | 208 | 0.00 |